Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.

Chen A, Xu J.

Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G447-56. Epub 2004 Oct 14.

PMID:
15486348
3.

CCK-B/gastrin receptors in human colorectal cancer.

Schmitz F, Otte JM, Stechele HU, Reimann B, Banasiewicz T, Fölsch UR, Schmidt WE, Herzig KH.

Eur J Clin Invest. 2001 Sep;31(9):812-20. Erratum in: Eur J Clin Invest 2002 Jan;32(1):69.

PMID:
11589724
5.

IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.

Pitulis N, Papageorgiou E, Tenta R, Lembessis P, Koutsilieris M.

Anticancer Res. 2009 Jun;29(6):2331-7.

6.

Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.

Qiao L, Dai Y, Gu Q, Chan KW, Zou B, Ma J, Wang J, Lan HY, Wong BC.

Mol Cancer Ther. 2008 Jul;7(7):2203-11. doi: 10.1158/1535-7163.MCT-08-0326.

7.
8.

Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2.

Chen L, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, Thompson EA.

J Biol Chem. 2006 Aug 25;281(34):24575-87. Epub 2006 Jun 30.

9.

Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.

Yan J, Yang H, Wang G, Sun L, Zhou Y, Guo Y, Xi Z, Jiang X.

Autophagy. 2010 Jan;6(1):67-73. Epub 2010 Jan 27.

PMID:
19923924
10.

Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.

Nonaka M, Tazuma S, Hyogo H, Kanno K, Chayama K.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e198-206. Epub 2007 Sep 14.

PMID:
17868335
11.

PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.

Lachal S, Ford J, Shulkes A, Baldwin GS.

Regul Pept. 2004 Aug 15;120(1-3):243-51.

PMID:
15177943
12.

Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.

Li X, Yang X, Xu Y, Jiang X, Li X, Nan F, Tang H.

Cell Res. 2009 Jun;19(6):720-32. doi: 10.1038/cr.2009.53.

PMID:
19417774
13.
14.

Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation.

Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, Terauchi Y, Tachibana M, Miyoshi H, Kamisaki Y, Mayumi T, Kadowaki T, Blumberg RS.

J Biol Chem. 2006 May 5;281(18):12673-81. Epub 2006 Mar 8.

15.

Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.

Meng D, Shi X, Jiang BH, Fang J.

Free Radic Biol Med. 2007 Jun 1;42(11):1651-60. Epub 2007 Jan 30.

PMID:
17462533
16.
17.

Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.

Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.

Clin Cancer Res. 2008 Jul 1;14(13):4045-52. doi: 10.1158/1078-0432.CCR-07-5040.

18.

Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.

Achanzar WE, Moyer CF, Marthaler LT, Gullo R, Chen SJ, French MH, Watson LM, Rhodes JW, Kozlosky JC, White MR, Foster WR, Burgun JJ, Car BD, Cosma GN, Dominick MA.

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):246-56. Epub 2007 Jul 3.

PMID:
17663016
19.

The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.

Huang H, Ansorge N, Schrader H, Banasch M, Yu HG, Schmidt WE, Höcker M, Schmitz F.

Regul Pept. 2007 Dec 4;144(1-3):34-42. Epub 2007 Jun 7.

PMID:
17936921

Supplemental Content

Support Center